Modelling the I-O manufacturing facilities of tomorrow

IMMUNO-ONCOLOGY INSIGHTS

April 2021

Modelling the I-O manufacturing facilities of tomorrow

Download PDF

Foreword

Modelling the I-O manufacturing facilities of tomorrow

Modelling the I-O manufacturing facilities of tomorrow

Editorial

Outlook on manufacturing adoptive cell therapies for cancer immunotherapy

Outlook on manufacturing adoptive cell therapies for cancer immunotherapy

Xiuyan Wang, Isabelle Rivière

Expert Roundtable Video

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

John Lunger, Vijay Yabannavar, Donna Rill

Expert Roundtable

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?

Commentary

Future-proofing cell therapy manufacturing capability: lessons from the NCI

Future-proofing cell therapy manufacturing capability: lessons from the NCI

Anthony Welch, Marc Ernstoff, Jason Yovandich

Interview

Key considerations in delivering tomorrow’s biopharma manufacturing facilities and workforce

Key considerations in delivering tomorrow’s biopharma manufacturing facilities and workforce

Driving a new model for point of care cellular cancer immunotherapy manufacturing

Driving a new model for point of care cellular cancer immunotherapy manufacturing

J Powderly, R Brent Dixon, J Montague et al.